BioRestorative Therapies BRTX
NASDAQ BRTX
$1.57 +0.02 (+1.29%)
As of: Nov 11, 2026 · 3:59 PM EST

BioRestorative Therapies (BRTX) Current Leases (2019 - 2023)

Updated

Analysis

BioRestorative Therapies (BRTX) Current Leases (2019 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 BioRestorative Therapies 1.36 Mn -17.06 Mn 15,785.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 162,317.00
Sep 30, 2023 156,310.00
Jun 30, 2023 150,480.00
Mar 31, 2023 144,821.00
Dec 31, 2022 139,328.00
Sep 30, 2022 134,031.00
Jun 30, 2022 128,889.00
Mar 31, 2022 123,899.00
Dec 31, 2021 119,055.00
Sep 30, 2021 114,387.00
Dec 31, 2020 158,371.00
Dec 31, 2019 521,890.00
API Access

BioRestorative Therapies Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=BRTX&period=max&api_key=YOUR_API_KEY